Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP828632.RA6FHaY-LfpKGmpTJaq8GFbAipCoO6uPQw_pcr67G-ZFE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP828632.RA6FHaY-LfpKGmpTJaq8GFbAipCoO6uPQw_pcr67G-ZFE130_assertion type Assertion NP828632.RA6FHaY-LfpKGmpTJaq8GFbAipCoO6uPQw_pcr67G-ZFE130_head.
- NP828632.RA6FHaY-LfpKGmpTJaq8GFbAipCoO6uPQw_pcr67G-ZFE130_assertion description "[EGFR and FCGR3A germline polymorphisms are associated with PFS in KRAS wild-type mCRC patients treated with cetuximab, bevacizumab and chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP828632.RA6FHaY-LfpKGmpTJaq8GFbAipCoO6uPQw_pcr67G-ZFE130_provenance.
- NP828632.RA6FHaY-LfpKGmpTJaq8GFbAipCoO6uPQw_pcr67G-ZFE130_assertion evidence source_evidence_literature NP828632.RA6FHaY-LfpKGmpTJaq8GFbAipCoO6uPQw_pcr67G-ZFE130_provenance.
- NP828632.RA6FHaY-LfpKGmpTJaq8GFbAipCoO6uPQw_pcr67G-ZFE130_assertion SIO_000772 20418097 NP828632.RA6FHaY-LfpKGmpTJaq8GFbAipCoO6uPQw_pcr67G-ZFE130_provenance.
- NP828632.RA6FHaY-LfpKGmpTJaq8GFbAipCoO6uPQw_pcr67G-ZFE130_assertion wasDerivedFrom befree-20140225 NP828632.RA6FHaY-LfpKGmpTJaq8GFbAipCoO6uPQw_pcr67G-ZFE130_provenance.
- NP828632.RA6FHaY-LfpKGmpTJaq8GFbAipCoO6uPQw_pcr67G-ZFE130_assertion wasGeneratedBy ECO_0000203 NP828632.RA6FHaY-LfpKGmpTJaq8GFbAipCoO6uPQw_pcr67G-ZFE130_provenance.